CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Press Releases Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Market Closed - Nyse Other stock markets 04:00:02 2024-05-08 pm EDT			5-day change	1st Jan Change
235.3 ^USD	-0.43%		+1.12%	-0.47%

Apr. 25	FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids	CI
Apr. 24	Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP	May. 02	BU
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024	Apr. 24	PU
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally	Apr. 22	BU
Charles River Laboratories International : 2023 Corporate Citizenship Report	Apr. 21	PU
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing	Apr. 16	BU
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call	Apr. 15	AQ
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call	Apr. 12	BU
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology	Apr. 11	BU
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics	Apr. 09	BU
Charles River to Perform Plasmid Production for Ship of Theseus	Apr. 04	BU
Charles River to Perform Plasmid Production for Ship of Theseus	Apr. 04	BU
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024	Apr. 01	BU
Charles River Laboratories Publishes 2023 Corporate Citizenship Report	Mar. 27	BU
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine	Mar. 21	BU
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration	Mar. 14	BU
Charles River Laboratories to Present at Barclays Global Healthcare Conference	Mar. 12	BU
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use	Feb. 29	PR
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing	Feb. 21	BU
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells	Feb. 20	BU
Charles River: Q4 Earnings Snapshot	Feb. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Press Releases

Filters